Your search for major depressive disorder returned 53 results

Patients with psychotic depression who experienced an illness relapse while receiving placebo also had a decline in cortical thickness, emphasizing the essential role antipsychotics play in treating disorders where psychosis is present.

Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.

The study provides strong evidence for the utility of resting-state fMRI measures in predicting the development of attentional or mood disorders in children.

Researchers sought to address the possible link between cognitive or mood symptoms and statins.

The Food and Drug Administration (FDA) has granted Fast Track designation to an investigational intranasal formulation of racemic ketamine for the potential treatment of acute suicidal ideation and behavior in patients with major depressive disorder.

This newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.

Some nutrient supplements may be beneficial as adjunctive treatment for common mental health condition.

Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.

Lundbeck announced that the FDA has approved a sNDA for Trintellix to include data regarding improved processing speed.

For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.

Depression is one of the most commonly reported complications resulting from stroke.

The FDA has cleared Nexstim’s NBT system for the treatment of major depressive disorder.

Escitalopram may be better for the treatment of depression than tDCS.

Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.

Time spent on mobile phones and social media may contribute to the rise in depression.

HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.

Sixty percent of patients responded to treatment.

The drug was found to work quickly in patients with clinical major depression.

The device is used to condition the patient to reduce or stop their aggressive behavior.

Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.

Changes were more pronounced in depressed volunteers.

Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.

There was insufficient evidence to recommend screening in children aged 11 and younger.